Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 CAD | +0.95% |
|
+3.23% | +4.12% |
May. 17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
May. 17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.12% | 82.49M | |
+52.93% | 803B | |
+40.58% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.23% | 244B | |
+2.09% | 226B | |
+10.19% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- RX Stock
- News BioSyent Inc.
- Transcript : BioSyent Inc., Q4 2021 Pre Recorded Earnings Call, Mar 09, 2022